These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Clinical and pH-metric outcomes of transoral esophagogastric fundoplication for the treatment of gastroesophageal reflux disease. Bell RC; Freeman KD Surg Endosc; 2011 Jun; 25(6):1975-84. PubMed ID: 21140170 [TBL] [Abstract][Full Text] [Related]
10. Three-year results of a multicenter prospective study of transoral incisionless fundoplication. Muls V; Eckardt AJ; Marchese M; Bastens B; Buset M; Devière J; Louis H; Rajan A; Daniel MA; Costamagna G Surg Innov; 2013 Aug; 20(4):321-30. PubMed ID: 22968006 [TBL] [Abstract][Full Text] [Related]
11. A prospective multicenter registry of patients with chronic gastroesophageal reflux disease receiving transoral incisionless fundoplication. Bell RC; Mavrelis PG; Barnes WE; Dargis D; Carter BJ; Hoddinott KM; Sewell RW; Trad KS; DaCosta Gill B; Ihde GM J Am Coll Surg; 2012 Dec; 215(6):794-809. PubMed ID: 22939637 [TBL] [Abstract][Full Text] [Related]
12. Impact of transoral incisionless fundoplication (TIF) on subjective and objective GERD indices: a systematic review of the published literature. Wendling MR; Melvin WS; Perry KA Surg Endosc; 2013 Oct; 27(10):3754-61. PubMed ID: 23644835 [TBL] [Abstract][Full Text] [Related]
13. Univariate and multivariate analyses of preoperative factors influencing symptomatic outcomes of transoral fundoplication. Bell RC; Fox MA; Barnes WE; Mavrelis PG; Sewell RW; Carter BJ; Ihde GM; Trad KS; Dargis D; Hoddinott KM; Freeman KD; Gunsberger T; Hausmann MG; Gill BD; Wilson E Surg Endosc; 2014 Oct; 28(10):2949-58. PubMed ID: 24879134 [TBL] [Abstract][Full Text] [Related]
14. Concomitant hiatal hernia repair with transoral incisionless fundoplication for the treatment of refractory gastroesophageal reflux disease: a systematic review. Jaber F; Ayyad M; Ayoub F; Patel KK; Makris KI; Hernaez R; Skef W Surg Endosc; 2024 Oct; 38(10):5528-5540. PubMed ID: 39271515 [TBL] [Abstract][Full Text] [Related]
15. Impact of second-generation transoral incisionless fundoplication on atypical GERD symptoms: a systematic review and meta-analysis. Haseeb M; Brown JRG; Hayat U; Bay C; Bain PA; Jirapinyo P; Thompson CC Gastrointest Endosc; 2023 Mar; 97(3):394-406.e2. PubMed ID: 36402203 [TBL] [Abstract][Full Text] [Related]
16. Long-term efficacy of transoral incisionless fundoplication with Esophyx (Tif 2.0) and factors affecting outcomes in GERD patients followed for up to 6 years: a prospective single-center study. Testoni PA; Testoni S; Mazzoleni G; Vailati C; Passaretti S Surg Endosc; 2015 Sep; 29(9):2770-80. PubMed ID: 25480624 [TBL] [Abstract][Full Text] [Related]
17. Transoral Incisionless Fundoplication (TIF 2.0): A Meta-Analysis of Three Randomized, Controlled Clinical Trials. Gerson L; Stouch B; Lobonţiu A Chirurgia (Bucur); 2018; 113(2):173-184. PubMed ID: 29733015 [TBL] [Abstract][Full Text] [Related]
18. The TEMPO Trial at 5 Years: Transoral Fundoplication (TIF 2.0) Is Safe, Durable, and Cost-effective. Trad KS; Barnes WE; Prevou ER; Simoni G; Steffen JA; Shughoury AB; Raza M; Heise JA; Fox MA; Mavrelis PG Surg Innov; 2018 Apr; 25(2):149-157. PubMed ID: 29405886 [TBL] [Abstract][Full Text] [Related]
19. Long-term outcomes after transoral incisionless fundoplication in patients with GERD and LPR symptoms. Trad KS; Turgeon DG; Deljkich E Surg Endosc; 2012 Mar; 26(3):650-60. PubMed ID: 21959689 [TBL] [Abstract][Full Text] [Related]
20. The long-term efficacy of transoral incisionless fundoplication with Medigus Ultrasonic Surgical Endostapler (MUSE) for gastroesophageal reflux disease. Shen S; Yu G; Guo X; Zong G; Wang C; Bao J; Chen J; Cheng Z; Xiao W; Shen J; Jiang W; Wan R Esophagus; 2023 Jul; 20(3):581-586. PubMed ID: 36877412 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]